- Home
- EPOW vs TPST Comparison
EPOW vs TPST Comparison
Compare EPOW & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPOW
- TPST
- Stock Information
- Founded
- EPOW 2014
- TPST 2011
- Country
- EPOW China
- TPST United States
- Employees
- EPOW N/A
- TPST N/A
- Industry
- EPOW Business Services
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- EPOW Consumer Discretionary
- TPST Health Care
- Exchange
- EPOW Nasdaq
- TPST Nasdaq
- Market Cap
- EPOW 24.5M
- TPST 33.0M
- IPO Year
- EPOW 2021
- TPST N/A
- Fundamental
- Price
- EPOW $0.95
- TPST $7.26
- Analyst Decision
- EPOW
- TPST Hold
- Analyst Count
- EPOW 0
- TPST 3
- Target Price
- EPOW N/A
- TPST $30.00
- AVG Volume (30 Days)
- EPOW 14.9K
- TPST 115.7K
- Earning Date
- EPOW 07-22-2025
- TPST 08-07-2025
- Dividend Yield
- EPOW N/A
- TPST N/A
- EPS Growth
- EPOW N/A
- TPST N/A
- EPS
- EPOW N/A
- TPST N/A
- Revenue
- EPOW $64,997,741.00
- TPST N/A
- Revenue This Year
- EPOW N/A
- TPST N/A
- Revenue Next Year
- EPOW N/A
- TPST N/A
- P/E Ratio
- EPOW N/A
- TPST N/A
- Revenue Growth
- EPOW 44.28
- TPST N/A
- 52 Week Low
- EPOW $0.55
- TPST $5.35
- 52 Week High
- EPOW $1.36
- TPST $30.03
- Technical
- Relative Strength Index (RSI)
- EPOW 63.10
- TPST 54.15
- Support Level
- EPOW $0.92
- TPST $7.06
- Resistance Level
- EPOW $0.96
- TPST $7.64
- Average True Range (ATR)
- EPOW 0.05
- TPST 0.26
- MACD
- EPOW 0.02
- TPST 0.05
- Stochastic Oscillator
- EPOW 99.88
- TPST 72.66
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.